Sage Journals: Discover world-class research

Abstract

BACKGROUND:

Annexin A5 (ANXA5) is a kind of Ca ${}^{2+}$ -dependent phospholipid binding protein which is involved in cell membrane dynamics and organization. Recent data showed that ANXA5 might involve in tumorigenesis.

OBJECTIVE:

To explore what role ANXA5 play in human uterine cervical carcinoma.

MATERIALS AND METHODS:

In this study, a recombined ANXA5 plasmid was constructed and uterine cervical carcinoma cell lines HeLa and SiHa were transfected with it. After ANXA5 overexpression was determined by Western Blot, cell proliferation test was detected by MTT assay and colony formation assay respectively. FACS assay and Hochest33258 staining methods were employed to detect cell apoptosis. To further investigate whether ANXA5 influence cell migration and invasion, wound healing assay and transwell assay were applied. At the same time, the relative mechanism was investigated.

RESULTS:

When ANXA5 expression increased, cell proliferation was inhibited by regulating the expression of bcl-2 and bax while cell metastasis was suppressed by regulating E-cadherin and MMP-9 expression.

CONCLUSION:

ANXA5 overexpression in the uterine cervical carcinoma might play important roles in cell proliferation and metastasis of uterine cervical cancer cells and act as an anti-cancer gene in uterine cervical cancer.

Keywords

ANXA5 uterine cervical carcinoma cell proliferation apoptosis invasion migration

1. Introduction

Cervical cancer incidence and mortality is the fourth leading cause of death in females worldwide and the second leading cause of mortality among women aged 19–39 years [1], with 500,000 new cases and 250,000 deaths annually worldwide [2]. Although the association between human papilloma virus and tumorigenesis of uterine cervical carcinoma has been clarified, however, whether there are any oncogene activated or suppressor gene inactivated still largely remains elusive. Annexins are a well-known multigene family of Ca ${}^{2+}$ dependent phospholipid binding proteins which contains 12 members (annexin A1, A2, …A11, A13). They have a unique architecture that allows them to dock onto membranes in a peripheral and reversible manner. The conserved core domain consists of four repeats, each of which is 70 residues in length. The N-terminal region preceding the core domain is diverse in sequence and length which mediates regulatory interactions with protein ligands and regulates the annexin-membrane association [3, 4]. Annexin A5 (ANXA5) has been reported to have anticoagulant activity [5] and be involved in the inhibition of phospholipase A and the regulation of membrane transport [6]. It has also been implicated in various cellular functions, including proliferation and signal transduction, although the precise role of ANXA5 has not yet been identified. But the increased expression in colorectal carcinoma, pancreatic cancer, bladder cancer, prostate cancer [7, 8, 9, 10, 11] and the decreased expression in thyroid cancer [12]implied ANXA5 might involve in the development of various neoplasm. It had been reported that ANXA5 was associated with hepatocarcinoma lymphatic metastasis [13, 14] and its up-regulation suppressed Ras activation by decreasing the association of Shc with Grb2 [15]. Our previous study had found that ANXA5 expression increased in human uterine cervical carcinoma [16], however, whether ANXA5 play any role in the development of human uterine cervical carcinoma has not been identified. Therefore, in the present study, the effect of ANXA5 on the behavior of the uterine cervical carcinoma cell lines was investigated. In addition, the expression of relative genes were detected to explore the underlying mechanisms.

2. Materials and methods

2.1 Cell culture

Human uterine cervical carcinoma cell line HeLa and SiHa were obtained from Shanghai Academy of Medical Sciences (Shanghai, China). The cells were incubated at 37 ${}^{\circ}$ C in 5% CO ${}_{2}$ in plastic tissue culture flasks (Corning Inc., Acton, MA, USA) with complete Dulbecco’s modified Eagle’s medium (DMEM) (Gibco-BRL, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS; Gibco-BRL). Cobble-shaped cells began to expand after two days. At about 80% confluence, the cells were separated by digestion with 0.25% trypsin-EDTA (Gibco-BRL) and passaged into three plastic tissue culture flasks in the growth medium for expansion.

2.2 RT-PCR

Total RNA was isolated from HeLa or SiHa cells with the TRIzol reagent kit according to the manufacturer’s instructions. RNA (2 $\mu$ g) was reverse-transcribed with 10,000 units of reverse transcriptase and 0.5 $\mu$ g/ $\mu$ l oligo-(dT) primer in 20 $\mu$ l RT buffer (1 $\times$ Superscript II RT buffer, 10 mM DTT and 0.025 mM dNTP) at 25 ${}^{\circ}$ C for 5 min, followed by 50 ${}^{\circ}$ C for 50 min. Reverse transcriptase was inactivated at 70 ${}^{\circ}$ C for 15 min. The primer sequences were obtained from GenBank (NCBI Reference Sequence: CR536522.1) as followed: forward: 5’ ATGGCACAG GTTCTCAGAGGCACTG 3’, reverse: 5’ TTAGTCAT CTTCTCCACAGAGCAGC 3’ with a 959 bp product. PCR was performed in 50 $\mu$ l of 10 mM Tris-HCl (pH 8.3), 25 mM MgCl ${}_{2}$ , 10 mM dNTP, 100 units Taq DNA polymerase and 0.1 $\mu$ M of each primer. The reactions were initiated at 94 ${}^{\circ}$ C for 5 min and amplified for 30 cycles of 30 sec at 94 ${}^{\circ}$ C, 30 sec at 58 ${}^{\circ}$ C and 30 sec at 72 ${}^{\circ}$ C. Final extensions were performed for 7 min at 72 ${}^{\circ}$ C to complete the polymerization. The PCR products were resolved on a 1% agarose gel and analyzed using a digital image analysis system. All experiments were performed at least three times, with similar results.

2.3 ANXA5 vector generation and identification

The pcDNA3.1 empty plasmid was obtained from Jikai Biological Engineering Company (Shanghai,China). Both pcDNA3.1 empty plasmid and ANXA5 nucleotide were sliced by BamHI and XhoI incision enzyme so as to obtain sticky ends. The sliced plasmid and the nucleotide was linked by T4 ligase so as to construct the recombined ANXA5 plasmid which was named plasmid pcDNA3.1-ANXA5. Then the recombined plasmid was transformed into DH5 $\alpha$ competent cell and the plasmid was abstracted which was digested by BamHI and XhoI incision enzyme to identify whether it was successfully constructed. To further confirm the sequence of the whole ANXA5 gene, it was sequenced by Jikai Biological Engineering Company (Shanghai, China).

2.4 Plasmid transfection of HeLa and SiHa cells

The transfection reagent lipofectamine2000 was purchased from Invitrogen (Invitrogen Co., Carlsbad, CA, USA). At about 50–70% confluence, cells were transfected with the recombined pcDNA3.1-ANXA5 plasmid and the pcDNA3.1 empty plasmid respectively according to the manual. Six hours later, the transfection medium was replaced with complete growth DMEM. Twenty-four hours later, 800 $\mu$ g/ml G418 was added to the cells. After two weeks, 800 $\mu$ g/ml G418 was replaced to 400 $\mu$ g/ml to remain the pressure. In addition, the recombinant pcDNA3.1-ANXA5 transfected cells were designated HeLa/ANXA5 or SiHa/ANXA5. Cells transfected with pcDNA3.1 empty plasmid served as a negative control (HeLa/Neo or SiHa/Neo). The cells without any treatment were designated Blank.

2.5 Western blot analysis

The cells were homogenized in a single detergent lysis buffer (50 mM Tris, pH 8.0; 150 mM NaCl; 1% Triton X-100; and 0.5% each of protease and phosphatase inhibitor cocktails) and then centrifuged at 12,000 $\times$ g for 20 min at 4 ${}^{\circ}$ C. The supernatants were transferred into new tubes, assayed for protein content using a protein assay kit, aliquoted at a concentration of 5 $\mu$ g/20 $\mu$ l in lysis buffer and stored at $-$ 80 ${}^{\circ}$ C. Alternatively, they were used on the same day. The samples were mixed with loading buffer (100 mM Tris, pH 6.8; 200 mM DTT; 4% SDS; 20% glycerol; and 0.2% bromophenol blue) at a 1:1 dilution, boiled for 5 min, quickly chilled on ice and then separated on 10% SDS-polyacrylamide Tris-glycine gels. The proteins were then transferred onto polyvinylidene difluoride membranes and treated with 5% non-fat dry milk in 1 $\times$ phosphate-buffered saline-Tween (PBST) (1.46 mM NaH ${}_{2}$ PO ${}_{4}$ H ${}_{2}$ O; 8.05 mM Na ${}_{2}$ HPO ${}_{4}$ ; and 144.72 mM NaCl; 5% Tween-20) for 2 h. The membranes were reacted with monoclonal antibodies at 1:1,000 dilution overnight at 4 ${}^{\circ}$ C and then reacted with HRP-conjugated goat anti-mouse antibodies for 1 h at room temperature. The bound antibodies were detected by chemiluminescence according to the manufacturer’s instructions and quantified using a digital image analysis system. All experiments were performed three times in triplicate.

2.6 MTT assay

Cell suspensions (100 $\mu$ l) were dispensed into 96-well round-bottomed microtiter plates (3,000 cells/well) and incubated for 12–72 h at 37 ${}^{\circ}$ C in 5% CO ${}_{2}$ . At every time point, 5 mg/ml of sterile MTT was added into each well and incubated at 37 ${}^{\circ}$ C for 4 h. After aspiration of the medium, 150 ml of DMSO (Sigma, St. Louis, MO, USA) were added and mixed, and absorbance was determined at 490 nm with a spectrophotometer (Spectramax 190; Molecular Devices, Sunnyvale, CA, USA). Growth curves were generated from the average values of eight wells in each group.

2.7 Colony formation assay

The cells (6 $\times$ 10 ${}^{2}$ /well) were seeded in 12-well plates and incubated in DMEM medium containing 10% FBS at 37 ${}^{\circ}$ C with 5% CO ${}_{2}$ for 14 days. Subsequently, the cells were fixed with 4% paraformaldehyde for 30 min and then stained with 0.1% crystal violet (Beyotime, Shanghai, China) for 30 min. The number of colonies containing $\geqslant$ 10 cells was counted and representative images were obtained.

2.8 Fluorescence microscopy

Cells at the logarithmic-growth phase were seeded into 96-well plates (1 $\times$ 10 ${}^{4}$ /well) and cultured for 48 h, washed with PBS and stained with Hoechst 33258 (Sigma-Aldrich) for 30 min at 37 ${}^{\circ}$ C. Cells were then observed under a Nikon 80i fluorescence microscope equipped with a UV filter (Nikon Corporation, Tokyo, Japan). For every well, five view fields were chosen randomly and the apoptotic cells were counted.

2.9 Analysis of apoptosis by FACS assay

Cell apoptosis was analyzed by flow cytometry (FACSAria II; BD Biosciences, Franklin Lakes, NJ, USA). Cultured cells were washed twice with phosphate-buffered saline (PBS) and resuspended in binding buffer at 1 $\times$ 10 ${}^{6}$ cells/ml. Cell suspensions (1 $\times$ 10 ${}^{5}$ cells/100 $\mu$ l) were transferred to 5 ml culture tubes, and 5 $\mu$ l Annexin V-FITC (eBioscience, San Diego, CA, USA) and 5 $\mu$ l PI (eBioscience) were then added. The cells were gently vortexed and incubated at room temperature in the dark for 15 min. Subsequently, another 400 $\mu$ l binding buffer was added. Flow cytometry was performed within 4 h staining.

2.10 Wound healing assay

When the cells reached 80–85% confluence, they were scratched with a micropipette tip in the cell monolayer. After 48 h incubation, recovery of the wound was observed and images were captured by a phase-contrast microscope.

2.11 Cell invasion assay

The cell invasion assay was performed using the QCM 24-well cell invasion assay kit (Millipore, Billerica, MA, USA). Each lower chamber contained an additional 600 ml of 0.5% FBS as the chemoattractant. Cells (1 $\times$ 10 ${}^{5}$ ) were placed into the upper chamber and then incubated for 48 h at 37 ${}^{\circ}$ C in a humidified atmosphere containing 5% CO ${}_{2}$ . After incubation, non-migrating cells in the top chambers were completely removed with a cotton bud. Cells that invaded into the lower chambers were fixed in 95% methanol for 15 min, stained with 0.1% crystal violet for 10 min prior to washing with water and counted in five random fields with an inverted microscope.

Figure 1.

Identification of ANXA5 gene sequence in recombined pcDNA3.1-ANXA5 plasmid by enzyme digestion and sequencing. A. The result of enzyme digestion of pcDNA3.1-ANXA5; B. The sequencing of pcDNA3.1-ANXA5 plasmid in HeLa cells; C. The sequencing of pcDNA3.1-ANXA5 plasmid in SiHa cells.

After dyeing, the lower membrane was decolorized with 33% acetic acid, and the crystal violet was completely eluted. The eluent was measured with a spectrophotometer (Spectramax 190; Molecular Devices, Sunnyvale, CA, USA) at 570 nm. Each assay was replicated three times.

2.12 Statistical analysis

Each experiment was performed at least three times. All the data were expressed as means $\pm$ standard error of mean (SED). Statistical analysis was performed using Student’s t-test with the SPSS 19.0 statistical software package (SPSS Inc, Chicago, IL, USA). The threshold of statistical significance was defined as $P<$ 0.05.

3. Results

3.1 The recombined pcDNA3.1-ANXA5 plasmid was successfully constructed

After digested by BamHI and XhoI incision enzyme, the plasmid was put in the agarose gel electrophoresis and at about 1000 bp level, ANXA5 band was observed (Fig. 1A). To assure none of the bases is mistake, the plasmid was sent to the biological company to be sequenced. The result of the sequencing assay confirmed all the bases of ANXA5 gene in the recombined plasmid were correct (Fig. 1B and C).

Figure 2.

Screening of ANXA5 overexpression in HeLa and SiHa cells by Western Blot method. ANXA5: the cells transfected with pcDNA3.1-ANXA5 plasmid; Neo: the cells transfected with pcDNA3.1 empty plasmid; Blank: the cells without any treatment. ANXA5 cells group has a significant difference compared with Neo and Blank cells. * $P<$ 0.0001.

Figure 3.

Alteration of ANXA5 overexpression cells in morphology. Original magnification $\times$ 400. A: HeLa cells transfected with pcDNA3.1-ANXA5 plasmid. B: HeLa cells transfected with pcDNA3.1 empty plasmid. C: HeLa cells without any treatment. D: SiHa cells transfected with pcDNA3.1-ANXA5 plasmid. E: SiHa cells transfected with pcDNA3.1 plasmid. F: SiHa cells without any treatment.

3.2 Identification of ANXA5 overexpression in HeLa and SiHa cells

The recombined pcDNA3.1-ANXA5 plasmid was transfected into HeLa cells and SiHa cells respectively with the transfect reagent lipofectimin2000. G418 was used to screen the positive cell clones and two weeks later, the stably ANXA5 transfected cell clones were obtained. To detect whether ANXA5 was overexpressed, Western blot method was applied and ANXA5 overexpression in HeLa(SiHa)/ANXA5 cells groups was confirmed ( $P<$ 0.0001) (Fig. 2).

3.3 Cells morphology under the inverted microscope

The HeLa (SiHa)/ANXA5 cells became looser and irregular, some became thinner and longer like fibroblasts while some became swelled with a prominent nucleolus, rather different from the Neo or Blank cells which were polygonous and grouped together like “paving stones” (Fig. 3).

3.4 ANXA5 overexpression suppressed the proliferation of HeLa or SiHa cells

Cell proliferation test was determined by MTT assay and colony formation assay respectively. In MTT assay, subsequent to culture for 12, 24, 36, 48 and 72 h, the in vitro growth of the HeLa (SiHa)/ANXA5 cells was significantly lower than that of either the Neo or Blank groups at all time points ( $P<$ 0.0001). No significant differences were detected between the latter two groups at time point (Fig. 4A). In the colony formation assay, the number of cell clones in the HeLa (SiHa)/ANXA5 plate was significantly less than that in both Neo and Blank plates (Fig. 4B).

Figure 4.

Proliferation of ANXA5 overexpression HeLa or SiHa cells by MTT assay and colony formation assay. A. MTT assay. B. Colony formation assay. ANXA5 cells group has a significant difference compared with Neo and Blank cells. * $P<$ 0.0001.

Figure 5.

Apoptotic HeLa or SiHa cells stained by Hochest 33258 and FACS assay respectively. A. FACS assay. B. Hochest 33258 staining. Original magnification $\times$ 400. ANXA5 cells group has a significant difference compared with Neo and Blank cells. * $P<$ 0.0001.

Figure 6.

Cell metastasis assay. A. Migration detection by wound healing assay. B. Invasion detection by transwell assay. C. OD570 of the transferred cells. Forty-eight hours after transfection, the ANXA5/HeLa or ANXA5/SiHa cells appeared limited metastasis ability. The difference was significant. * $P<$ 0.0001.

Figure 7.

Bcl-2, Bax, E-cadherin and MMP-9 expression by Western Blot. The expression of bax and E-cadherin increased while that of bcl-2 and MMP-9 deceased. ANXA5 cells group has a significant difference compared with Neo and Blank cells. * $P<$ 0.0001.

3.5 ANXA5 overexpression prompted HeLa or SiHa cells apoptosis

FACS assay and Hochest33258 staining methods were employed. In FACS assay, apoptotic cells in the Hela (SiHa)/ANXA5 group were more than those in both Neo and Blank groups ( $P<$ 0.0001) (Fig. 5A). In Hochest33258 staining method, apoptosis was determined by condensed and fragmented nuclei. The number of HeLa (SiHa)/ANXA5 cells stained by Hochest 33258 was 7.8 $\pm$ 0.34 and 6.8 $\pm$ 0.2 with the Neo 1.3 $\pm$ 0.08/1.4 $\pm$ 0.10 and Blank 2.4 $\pm$ 0.14/2.5 $\pm$ 0.19. Cells apoptosis was significantly increased when compared with HeLa (SiHa)/Neo cells and Blank cells ( $P<$ 0.0001) and no significant differences were detected between the latter two ( $P>$ 0.05) (Fig. 5B).

3.6 ANXA5 overexpression suppressed cell metastasis of uterine cervical cancer cells

To further investigate whether ANXA5 influence cell metastasis, wound healing assay and transwell assay were applied. As shown in Fig. 6A, forty eight hours after the plasmid pcDNA3.1-ANXA5 transfection into the cells, both the ANXA5/Hela and ANXA5/SiHa cells showed limited ability to migrate while the width of the scratch borders in the Neo cells reduced significantly. We then detected the invasion ability of the transfected cells by transwell assay. An obviously decreased number of ANXA5/HeLa or ANXA5/SiHa cells compared to the Neo and Blank cells was detectable which might be attributed to a reduced invasion ability (Fig. 6B). We further collected the eluent of the decolorized lower membrane and detected the absorbance value at 570 nm. The OD570 of the ANXA5 overexpression cell group significantly decreased (Fig. 6C).

3.7 Gene expression

To detect the mechanism of ANXA5 on the behavior of the uterine cervical carcinoma cells, the expression of bcl-2, bax, E-cadherin and MMP-9 was further detected. The decreased bcl-2 and the increased bax expression of the ANXA5/HeLa and ANXA5/SiHa cells indicated that ANXA5 might suppress cell proliferation ability by regulating bcl-2 and bax expression. Similarly, the increased E-cadherin expression and decreased MMP-9 expression implied ANXA5 might suppress cell migration and invasion by up-regulating E-cadherin while down-regulating MMP-9 expression (Fig. 7).

4. Discussion

Previously, we found ANXA5 was up-regulated in uterine cervical cancer [16]. However, the detailed functions ANXA5 might exert had not been discussed. Thus, in this study, we investigated the role of ANXA5 in uterine cervical cancer cells. Our results implied that ANXA5 might act as an anti-cancer protein which could suppress cell proliferation and prompt apoptosis by regulating bcl-2 and bax expression. In addition, ANXA5 could suppress cell migration and invasion by up-regulating E-cadherin and down-regulating MMP-9 expression.

ANXA5 could suppress proliferation and prompt apoptosis in uterine cervical carcinoma cells. Although DT40 cells were found resistant to apoptosis if lacking ANXA5 protein [17] and the interaction of ANXA5 and beta5 integrin can regulate the apoptosis of the growth plate chondrocytes [18], the biological function of endogenous ANXA5 is still unclear. Here, both MTT and colony formation assay were used to detect cell proliferation and the results suggested ANXA5 overexpression inhibited the cell viability which was in line with the report that ANXA5 inhibits neuroblastoma growth in vivo [19]. However, ANXA5 can promote cell proliferation in the cell lines of cholangiocarcinoma [20] and renal carcionoma [21], which is contrary to our results, suggesting that ANXA5 may play a different role in different tumor cells. With the light microscope, we found when ANXA5 was up-regulated, the cobble-shaped cells became fusiform, and some turned to round shape and died finally. To identify ANXA5 influence on cell apoptosis, both FACS assay and Hochest33258 staining methods were used. Apparent increasing chromatic cells were observed in the ANXA5 overexpression cells as with that ANXA5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystals [22]. The apoptosis induced by cisplatin in renal cells [23] and by tetramethoxystilbene in human breast cancer cells demonstrated that ANXA5 translocated from cytoplasm to mitochondria with significantly increased voltage-dependent anion channel (VDAC) oligomerization and apoptosis inducing factor (AIF) release. Knockdown of ANXA5 induced both VDAC oligomerization and AIF release decreased significantly [24] so that ANXA5 may enhance apoptosis through VDAC oligomerization in human prostate cancer cells and laryngeal cancer cells [25, 26]. These reports implied ANXA5 took part in the process of cell apoptosis. Among the most important mechanisms about cell apoptosis are the abnormal expression of anti-apoptotic genes and pro-apoptotic genes [27]. Bcl-2 family proteins have long been recognized as crucial mediators of mitochondrial apoptotic signaling [28, 29]. Bcl-2 protein mainly locates on the membrane of mitochondria where distributes permeability transition pore (PT) complex which VDAC had been suggested to participate in. Bax was in the cytoplasm and once activated, translocates to the mitochondria membrane and was implied to control the opening of PT complex [30, 31, 32]. Bax translocating to the mitochondria outer membrane induce the decrease of Bcl-2/Bax and the increase of Bax/Bax, which resulted in the increase of PT complex and the increased release of AIF and cytochrome C [33]. Therefore, Bcl-2 and bax expression was detected respectively. Our data showed ANXA5 could suppress Bcl-2 while promote Bax expression which implied the mitochondria membrane permeability increased and cytochrome C overflowed which leading to cell apoptosis.

ANXA5 could suppress uterine cervical carcinoma cells migration and invasiveness. To access whether ANXA5 involve in cell metastasis, wound healing assay and transwell assay were employed and the data clearly showed ANXA5 could suppress cell metastasis. These results are in agreement with a study on lung carcinoma cells where ANXA5 inhibited the migration of these cells [34], a study on diffuse large B-cell lymphoma where overexpression of ANXA5 significantly decreased cell invasion, MMP-9 expression and PI3K phosphorylation [35], but in contrast to the study carried out in oral carcinoma cells [11], normal human keratinocytes [36], corneal epithelium [37] and murine hepatocarcinoma cells [38] where a promotion of cell migration by ANXA5 was demonstrated. An explanation for this opposite results might be that ANXA5 exert specific effects on different tumors and different biological species. In addition, we analyzed ANXA5 within its physiological concentration whereas in the study on the corneal epithelium, extracellular ANXA5 protein was applied. To detect the mechanism of ANXA5 involving in cell metastasis, E-cadherin and MMP-9 expression was investigated. E-cadherin is a calcium dependent cell-cell glycoprotein which is thought to contribute to suppression in cancer by decreasing proliferation, invasion and metastasis. MMP-9 is an enzyme that belong to the zinc-metalloproteinases family which involved in the degradation of the extracellular matrix [39]. Both E-cadherin and MMP-9 are regarded as the important members in the process of epithelial-mesenchymal transition (EMT) which is the main mechanism of cell metastasis. We found ANXA5 overexpression could increase E-cadherin but decrease MMP-9 expression. With the result of suppressing cell proliferation, we speculate that ANXA5 might act as an anti-cancer protein during the development of human uterine cervical carcinoma.

In summary, we clarified that ANXA5 up-regulation could suppress cell proliferation and metastasis which implied ANXA5 might act as a tumor suppressor gene on the uterine cervical cancer cells. We have to point out that our results are lack of ANXA5 knockdown in the cells which is the next step of our study. Furthermore, genes in EMT such as snail, slug, vimentin will be detected later and the detailed mechanism of ANXA5 acting on the cancer cells will be investigated in the future.

Footnotes

Acknowledgments

The present study was supported by the Key Subjects in University of Hebei Province (grant No. 2013-4), by the Science and Technology Agency (grant No. 10276142) and by the Education Department of Hebei Province (grant No. Z2014026).

Conflict of interest

The authors declare no conflict of interest.

References

Jemal

Bray

Center

M.M.

Ferlay

Ward

and Forman

, Global cancer statistics, CA: A Cancer Journal for Clinicians 61 (2011), 69–90.

Torre

L.A.

Bray

Siegel

R.L.

Ferlay

Lortettieulent

and Jemal

, Global cancer statistics, 2012, CA: A Cancer Journal for Clinicians 65 (2015), 87–108.

Gerke

and Moss

S.E.

, Annexins: From structure to function, Physiological Reviews 82 (2002), 331–371.

Laohavisit

and Davies

J.M.

, Annexins, New Phytologist 189 (2011), 40–53.

Lizarbe

M.A.

Barrasa

J.I.

Olmo

Gavilanes

and Turnay

, Annexin-phospholipid interactions, functional implications, International Journal of Molecular Sciences 14 (2013), 2652–2683.

Krey

J.F.

Drummond

Foster

Porsov

Vijayakumar

Choi

Friderici

Jones

S.M.

Nuttall

A.L.

and Barr-Gillespie

P.G.

, Annexin A5 is the most abundant membrane-associated protein in stereocilia but is dispensable for hair-bundle development and function, Scientific Reports 6 (2016), srep27221.

Xue

Hao

L.Q.

Ding

F.X.

Mei

Huang

J.J.

C.G.

Yan

H.L.

and Sun

S.H.

, Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas, Journal of Clinical Gastroenterology 43 (2009), 831–837.

Cui

Zhang

Jia

Zhang

and Han

, Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma, Cancer Investigation 27 (2009), 747–755.

Mitra

A.P.

Almal

A.A.

George

Fry

D.W.

Lenehan

P.F.

Pagliarulo

Cote

R.J.

Datar

R.H.

and Worzel

W.P.

, The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer, BMC Cancer 6 (2006), 159.

10.

Lee

E.K.

Cho

and Kim

C.W.

, Proteomic analysis of cancer stem cells in human prostate cancer cells, Biochemical and Biophysical Research Communications 412 (2011), 279–285.

11.

Wehder

Arndt

Murzik

Bosserhoff

A.K.

Kob

von Eggeling

and Melle

, Annexin A5 is involved in migration and invasion of oral carcinoma, Cell Cycle 8 (2009), 1552–1558.

12.

Sofiadis

Becker

Hellman

Hultin-Rosenberg

Dinets

Hulchiy

Zedenius

Wallin

Foukakis

Höög

Auer

Lehtiö

and Larsson

, Proteomic profiling of follicular and papillary thyroid tumors, European Journal of Endocrinology 166 (2012), 657–667.

13.

Sun

M.Z.

Liu

Tang

Wang

Gong

Sun

and Greenaway

, Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis, Proteomics 9 (2009), 3285–3302.

14.

Sun

M.Z.

Liu

and Tang

, Proteomics investigation of mouse hepatocarcinoma cell lines with different lymph node metastasis capacities, Chem J Chin Univ 30 (2009), 517–524.

15.

Sato

Ogata

and Luca

L.M.D.

, Annexin V inhibits the 12-O-tetradecanoylphorbol-13-acetate-induced activation of Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of Shc in MCF-7 cells, Oncogene 19 (2000), 2904.

16.

Chen

Liang

X.J.

Gao

Y.F.

Wang

X.J.

Yan

and Gao

F.L.

, Annexin A5 protein expression is associated with the histological differentiation of uterine cervical squamous cell carcinoma in patients with an increased serum concentration, Molecular Medicine Reports 6 (2012), 1249–1254.

17.

Hawkins

T.E.

Das

Young

and Stephen

, DT40 cells lacking the Ca2+ -binding protein annexin 5 are resistant to Ca2+ -dependent apoptosis, Proc Natl Acad Sci USA 99 (2002), 8054–8059.

18.

Wang

and Kirsch

, Annexin V/β5 integrin interactions regulate apoptosis of growth plate chondrocytes, Journal of Biological Chemistry 281 (2006), 30848–30856.

19.

Yan

Doffek

Yin

Krein

Phillips

Sugg

S.L.

Johnbon

and Shilyansky

, Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo , Cancer Immunology, Immunotherapy 61 (2012), 1917–1927.

20.

Ding

X.M.

J.X.

Wang

Z.S.

Yao

A.H.

Jiao

C.Y.

Qian

J.J.

Bai

X.C.

and Li

X.C.

, Effects of silencing annexin A5 on proliferation and invasion of human cholangiocarcinoma cell line, European Review for Medical and Pharmacological Sciences 21 (2017), 1477–1488.

21.

Tang

Qin

Han

Wang

Yang

Liu

B.J.

and Qin

et al., High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma, International Journal of Oncology 50 (2017), 1839–1847.

22.

H.K.

Monceau

Camors

Cohen-Solal

Charlemagne

and Lioté

, Annexin 5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystals, Annals of The Rheumatic Diseases 67 (2008), 1617–1625.

23.

Jeong

J.J.

Park

Kwon

Y.J.

D.J.

Moon

and Chun

Y.J.

, Role of Annexin A5 in cisplatin-induced toxicity in renal cells molecular mechanism of apoptosis, Journal of Biological Chemistry 289 (2014), 2469–2481.

24.

Hong

Park

and Chun

Y.J.

, Role of annexin a5 on mitochondria-dependent apoptosis induced by tetramethoxystilbene in human breast cancer cells, Biomolecules and Therapeutics 22 (2014), 519.

25.

Park

and Chun

Y.J.

, Auranofin promotes mitochondrial apoptosis by inducing annexin A5 expression and translocation in human prostate cancer cells, Journal of Toxicology and Environmental Health, Part A 77 (2014), 1467–1476.

26.

Liu

Zhou

Wen

Deng

and Liu

, Inhibition of Hep-2 cell apoptosis after annexin A5 knockdown, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery 49 (2014), 326–329.

27.

Reed

J.C.

, Apoptosis-based therapies, Nature Reviews Drug Discovery 1 (2002), 111–121.

28.

Gross

McDonnell

J.M.

and Korsmeyer

S.J.

, BCL-2 family members and the mitochondria in apoptosis, Genes and Development 13 (1999), 1899–1911.

29.

Czabotar

P.E.

Lessene

Strasser

and Adams

J.M.

, Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy, Nature Reviews Molecular Cell Biology 15 (2014), 49–63.

30.

Bernardi

Rasola

Forte

and Lippe

, The mitochondrial permeability transition pore: Channel formation by F-ATP synthase, integration in signal transduction, and role in pathophysiology, Physiological Reviews 95 (2015), 1111–1155.

31.

Bonora

Wieckowski

M.R.

Chinopoulos

Kepp

Kroemer

Galluzzi

and Pinton

, Molecular mechanisms of cell death: Central implication of ATP synthase in mitochondrial permeability transition, Oncogene 34 (2015), 1475–1486.

32.

Elrod

J.W.

Wong

Mishra

Vagnozzi

R.J.

Sakthievel

Goonasekera

S.A.

Karch

Gabel

Farber

Force

et al., Cyclophilin D controls mitochondrial pore-dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice, The Journal of Clinical Investigation 120 (2010), 3680.

33.

Brooks

and Dong

, Regulation of mitochondrial morphological dynamics during apoptosis by Bcl-2 family proteins: A key in Bak? Cell Cycle 6 (2007), 3043–3047.

34.

Balch

and Dedman

J.R.

, Annexins II and V inhibit cell migration, Experimental Cell Research 237 (1997), 259–263.

35.

Wang

Zhang

Liu

and Zhang

, Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling, Oncology Reports 32 (2014), 2557–2563.

36.

Nakao

Watanabe

and Maki

, A new function of calphobindin I (annexin V), The FEBS Journal 223 (1994), 901–908.

37.

Watanabe

Kondo

Mizuno

Yano

Nakao

Hattori

Kimura

and Nishida

, Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5, Investigative Ophthalmology and Visual Science 47 (2006), 1862–1868.

38.

Sun

Wei

Liu

Guo

Liu

and Sun

M.Z.

, Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/pc-Jun (Ser73) and E-cadherin, Biomedicine and Pharmacotherapy 84 (2016), 645–654.

39.

Vandooren

Steen

P.E.V.D.

and Opdenakker

, Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade, Critical Reviews in Biochemistry and Molecular Biology 48 (2013), 222–272.

Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells 1

Abstract

BACKGROUND:

OBJECTIVE:

MATERIALS AND METHODS:

RESULTS:

CONCLUSION:

Keywords

1. Introduction

2. Materials and methods

2.1 Cell culture

2.2 RT-PCR

2.3 ANXA5 vector generation and identification

2.4 Plasmid transfection of HeLa and SiHa cells

2.5 Western blot analysis

2.6 MTT assay

2.7 Colony formation assay

2.8 Fluorescence microscopy

2.9 Analysis of apoptosis by FACS assay

2.10 Wound healing assay

2.11 Cell invasion assay

3. Results

3.1 The recombined pcDNA3.1-ANXA5 plasmid was successfully constructed

3.3 Cells morphology under the inverted microscope

3.4 ANXA5 overexpression suppressed the proliferation of HeLa or SiHa cells

3.6 ANXA5 overexpression suppressed cell metastasis of uterine cervical cancer cells

3.7 Gene expression

4. Discussion

Footnotes

Acknowledgments

Conflict of interest

References